Andere Sprachen Exicure, Inc.

Aktien

A3DMHP

US30205M2008

XCUR

Markt geschlossen - Nasdaq Andere Börsenplätze 22:30:01 15.04.2024			% 5 Tage	% 1. Jan.
0.6084 ^USD	+4.90%		+4.20%	+4.84%

05.02.	Exicure, Inc. und Bluejay Therapeutics Inc. schließen eine Patentlizenzvereinbarung zur Entwicklung von Cavrotolimod für die Behandlung von Hepatitis ab	CI
2023	Wall Street wird am Freitag niedriger eröffnen; Beschäftigungswachstum übertrifft Prognosen	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

North American Morning Briefing : Stocks Struggle After New Records	22.03.
An unknown buyer agreed to acquire 39.3% stake in Exicure, Inc. from DGP Co.,Ltd. for KRW 6 billion.	29.02.
Exicure, Inc. and Bluejay Therapeutics Inc. Enter into a Patent License Agreement to Develop Cavrotolimod for the Treatment of Hepatitis	05.02.
Exicure, Inc. and Bluejay Therapeutics Inc. Enter into a Patent License Agreement to Develop Cavrotolimod for the Treatment of Hepatitis	05.02.
Wall Street Set to Open Lower Friday; Employment Growth Tops Forecasts	08.12.
Investors Look Ahead to Economic Indicators as US Futures Trend Lower in Friday's Premarket	08.12.
Top Premarket Gainers	08.12.
Exicure : Non-Reliance on Previously Issued Financial Report - Form 8-K	01.12.
Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-Q	28.11.
Northwestern University Notifies Exicure, Inc. that it Was Terminating the 2014 License	06.10.23
Exicure, Inc. Appoints Minhee Eom to the Board	27.09.23
Exicure Appoints New CEO, CFO	23.08.23
Exicure, Inc. Announces Appointment of New CEO and CFO and Changes to Board of Directors	23.08.23
Exicure, Inc. Announces Executive Changes	23.08.23
Exicure, Inc. Announces Chief Financial Officer Changes	23.08.23
Exicure, Inc. Announces Executive Changes	23.08.23
Exicure : Announces Appointment of New CEO and CFO and Changes to Board of Directors - Form 8-K	23.08.23
Exicure Inc Provides Information to Shareholders	23.08.23
North American Morning Briefing : China Trouble Hits Sentiment	18.08.23
Exicure, Inc. Reports Second Quarter 2023 Financial Results and Provides Corporate Update	14.08.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Exicure, Inc.

Aktien

A3DMHP

US30205M2008

XCUR

Andere Sprachen

Filter